Improving Prospective Memory Via Telehealth
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Multiple Sclerosis
Related studies linked through entity extraction aliases.
An Individualized-health eLibrary App for People With Multiple Sclerosis
- Status
- RECRUITING
- Phase
- NA
A Health Action Process Approach Online Intervention for People With Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Longitudinal Assessment of Iron Rims in MS Lesions
- Status
- RECRUITING
- Phase
- N/A
Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
COVID-19 Vaccine Biomarker Study in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Therapeutic Monitoring of Drugs Used in the Treatment of Multiple Sclerosis
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study to Evaluate White Matter Hyperintensities in Migraine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Electrical Stimulations on Pain, Functional Capacity and Quality of Life in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- NA
Robotics for Mobility Rehabilitation in MS
- Status
- COMPLETED
- Phase
- PHASE1
The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
- Status
- COMPLETED
- Phase
- N/A
Cannabis as a Complementary Treatment in Multiple Sclerosis
- Status
- RECRUITING
- Phase
- PHASE2
MS Spinal Mobilisation Study
- Status
- COMPLETED
- Phase
- NA
Diagnosic and Pronostic Values of Kappa and Lambda Free Light Chains in Central Nervous System Inflammatory Diseases
- Status
- COMPLETED
- Phase
- N/A
A Systems Approach to Understanding Disease Processes in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
COVID-19 Booster Vaccination in Persons With Multiple Sclerosis
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Safety and Efficacy of Intrathecal Rituximab in Patients With Multiple Sclerosis
- Status
- UNKNOWN
- Phase
- PHASE1
Sema 4A as a Marker for Inflammatory Disease in Multiple Sclerosis
- Status
- WITHDRAWN
- Phase
- N/A